{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:30:46Z","timestamp":1761183046449,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"\u201cZenyaku Kogyo Co., Ltd.\u201d"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jiac.2019.12.018","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:28:26Z","timestamp":1580171306000},"page":"520-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models"],"prefix":"10.1016","volume":"26","author":[{"given":"Hiroyoshi","family":"Ohsawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Enami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4482-5667","authenticated-orcid":false,"given":"Keiichi","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2013","series-title":"Antibiotic resistance threats in the United States","key":"10.1016\/j.jiac.2019.12.018_bib1"},{"key":"10.1016\/j.jiac.2019.12.018_bib2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2019.12.018_bib3","first-page":"565","article-title":"Staphylococcus aureus resistant to vancomycin\u2014United States, 2002","volume":"51","year":"2002","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.jiac.2019.12.018_bib4","first-page":"707","article-title":"Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus\u2014Minnesota and North Dakota, 1997\u20131999","volume":"48","year":"1999","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.jiac.2019.12.018_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/340353","article-title":"Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"34","author":"Stevens","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.12.018_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2019.12.018_bib7","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.12.018_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tips.2015.11.008","article-title":"Antibody-based biologics and their promise to combat Staphylococcus aureus infections","volume":"37","author":"Sause","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jiac.2019.12.018_bib9","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.vaccine.2013.04.002","article-title":"Vaccine review: \"Staphyloccocus aureus vaccines: problems and prospects.\"","volume":"31","author":"Jansen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2019.12.018_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/AAC.03918-14","article-title":"Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model","volume":"59","author":"Hilliard","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.12.018_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/1348-0421.12242","article-title":"Successful selection of an infection-protective anti-Staphylococcus aureus monoclonal antibody and its protective activity in murine infection models","volume":"59","author":"Ohsawa","year":"2015","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jiac.2019.12.018_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1517\/14712598.2015.1019857","article-title":"Anti-lipoteichoic acid monoclonal antibody (pagibaximab) studies for the prevention of staphylococcal bloodstream infections in preterm infants","volume":"15","author":"Patel","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jiac.2019.12.018_bib13","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(02)08713-5","article-title":"Genome and virulence determinants of high virulence community-acquired MRSA","volume":"359","author":"Baba","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2019.12.018_bib14","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/AAC.00135-15","article-title":"A\u00a0mutation of RNA polymerase \u03b2' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into \u2018slow VISA\u2019 (sVISA)","volume":"59","author":"Matsuo","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.12.018_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jiac.2014.08.001","article-title":"Multi-drug-resistant Staphylococcus aureus and future chemotherapy","volume":"20","author":"Hiramatsu","year":"2014","journal-title":"J\u00a0Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19303873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19303873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:59:29Z","timestamp":1761159569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19303873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1341321X19303873"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.12.018","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}